PND104 COMPARATIVE ADHERENCE TRAJECTORIES OF ORAL FINGOLIMOD AND INJECTABLE DISEASE MODIFYING AGENTS IN MULTIPLE SCLEROSIS

The requested reference [85282f1321120f8562e40ab385eeb2404f7d9324] no longer exists in our database. It has been replaced by the current reference: [a9e93e05cbf444312bf93d3723dff0cf1b846018]

Authors
Category Primary study
JournalValue Health
Year 2020
This article has no abstract
Epistemonikos ID: c705e589293e371d61169248fea9b4d4017be60d
First added on: May 20, 2020